title: [With paroxysmal nocturnal haemoglobinuria and treatment with eculizumab].
authors.forename: José Tomás
authors.initials: JT
authors.lastname: Algado
authors.forename: Rafael
authors.initials: R
authors.lastname: Luque
authors.forename: Ramiro
authors.initials: R
authors.lastname: Nuñez
authors.forename: Berta
authors.initials: B
authors.lastname: Sanchez
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D003182:Complement C5 / Q000037:antagonists & inhibitors; D005260:Female; D005334:Fever / Q000209:etiology; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008589:Meningococcal Infections / Q000209:etiology*; D022401:Meningococcal Vaccines; D008875:Middle Aged; D011135:Polysaccharides, Bacterial; D017192:Skin Diseases, Bacterial / Q000209:etiology*; D014657:Vasculitis / Q000209:etiology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5; D007166:Immunosuppressive Agents; C094429:Mencevax AC; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C481642:eculizumab